Patent · US Active

Antibody formulations and methods

US9089529B2 · kind B2 · utility

3Cited by

112References

9Claims

0Family size

Assignee

PROTHENA THERAPEUTICS LIMITED · IE

Inventors

Patrick Garidel · Norderstedt, DE
Isaac Craig HENDERSON · San Francisco, US
Pamela KLEIN · San Mateo, US

Key dates

Filing date	Oct 25, 2012
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Oct 25, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.